• Home
  • Events
  • VCCC Alliance Precision Oncology Forum: Case presentation of broadened activity of new PARP inhibitors
Back to all events
17 Jun 2022
  • VCCC Alliance
  • Peter MacCallum Cancer Centre
  • Murdoch Children's Research Institute
Precision Oncology Forum | Webinar | 2.45 - 4.00 pm

VCCC Alliance Precision Oncology Forum: Case presentation of broadened activity of new PARP inhibitors

The Molecular Tumour Board is now the "VCCC Alliance Precision Oncology Forum"

All are welcome to attend, join Dr Stephen Luen, Medical Oncologist, Peter MacCallum Cancer Centre who will Chair the VCCC Alliance Precision Oncology Forum, previously known as The Molecular Tumour Board. A multi-disciplinary style forum that provides opportunities to discuss new research topics in Precision Oncology, as well as interesting and novel cases illustrating the clinical implications of molecular pathology and targeted therapies. Cases are discussed on an individual, de-identified basis. This forum also features an educational presentation. 

Join Associate Professor Paul Ekert, Group Leader of the Translational Tumour Biology at the Children’s Cancer Institute, UNSW , for an exciting presentation on on Lessons from the ZERO Childhood Cancer precision medicine program. The case presentation for this forum will focus on broadened activity with new PARP inhibitors.

The ZERO Childhood Cancer program is a national study exploring the feasibility of comprehensive genome profiling of high-risk childhood cancers as a means to identify new therapy opportunities for children with few options available to them. The evidence from the ZERO study, and similar studies around the world, indicate that genomics can lead to improved patient outcomes. But there are other important lessons we are learning, including the important roles that preclinical experimental data might have in helping clinical decision making.

Associate Professor Ekert research interests include the molecular biology and therapeutic targeting of genomic drivers in paediatric cancer, with a focus on fusion oncogenes. He will will present on Lessons from the ZERO Childhood Cancer precision medicine program.

Associate Professor Paul Ekert

Associate Professor Paul Ekert is the Group Leader of the Translational Tumour Biology at the Children’s Cancer Institute, UNSW and is cross appointed at the Peter MacCallum Cancer Centre and Murdoch Children’s Research Institute.

Precision Oncology Forum
Friday 17 June
2.45 - 4.00pm
Get the latest in cancer news, events and more, direct to your inbox
Join a network of Victorian cancer researchers, clinicians and consumers to keep your finger on the pulse.